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ABSTRACT
In Escherichia coli the glmS gene encoding gluco-
samine 6-phosphate (GlcN-6-P) synthase GlmS is
feedback regulated by GlcN-6-P in a pathway that
involves the small RNA GlmZ. Expression of glmS is
activated by the unprocessed form of GlmZ, which
accumulates when the intracellular GlcN-6-P con-
centration decreases. GlmZ stabilizes a glmS tran-
script that derives from processing. Overexpression
of a second sRNA, GlmY, also activates glmS exp-
ression in an unknown way. Furthermore, mutations
in two genes, yhbJ and pcnB, cause accumulation
of full-length GlmZ and thereby activate glmS
expression. The function of yhbJ is unknown and
pcnB encodes poly(A) polymerase PAP-I known to
polyadenylate and destabilize RNAs. Here we show
that GlmY acts indirectly in a way that depends on
GlmZ. When the intracellular GlcN-6-P concentra-
tion decreases, GlmY accumulates and causes in
turn accumulation of full-length GlmZ, which finally
activates glmS expression. In glmZ mutants,
GlmY has no effect on glmS, whereas artificially
expressed GlmZ can activate glmS expression also
in the absence of GlmY. Furthermore, we show that
PAP-I acts at the top of this regulatory pathway by
polyadenylating and destabilizing GlmY. In pcnB
mutants, GlmY accumulates and induces glmS
expression by stabilizing full-length GlmZ. Hence,
the data reveal a regulatory cascade composed
of two sRNAs, which responds to GlcN-6-P and is
controlled by polyadenylation.
INTRODUCTION
In recent years it became evident that in bacteria many
genes are regulated at the post-transcriptional level in
addition to control of transcription initiation. In this
respect, the glmS gene encoding glucosamine-6-phosphate
synthase (GlmS) received much attention because in the
Firmicutes group of Gram-positive bacteria its expression
is feedback regulated by a riboswitch mechansim (1,2).
In this case, the glmS mRNA is capable to bind the product
of GlmS enzymatic activity, glucosamine 6-phosphate
(GlcN-6-P), leading to activation of an intrinsic ribozyme
that catalyzes self-cleavage of the glmS mRNA. This self-
cleavage initiates therapid degradationof the glmS mRNA
by RNase J1 shutting oﬀ GlmS synthesis (3). Recently,
it has been reported that in the Gram-negative bacterium
Escherichia coli synthesis of GlmS is likewise feedback
regulated by GlcN-6-P, but by a mechanism that involves a
small RNA rather than a riboswitch (4).
The synthesis of GlcN-6-P by GlmS is the rate-limiting
reaction in the hexosamine pathway that delivers pre-
cursor molecules for biosynthesis of peptidoglycan and
lipopolysaccharides (LPS), which are essential elements of
bacterial cell walls and Gram-negative outer membranes.
In E. coli, glmS is encoded in the bi-cistronic glmUS
operon that is transcribed from two promoters in
front of glmU (5). The primary glmUS transcripts are
subject to processing by RNase E at the glmU stop codon
(4,6). Upon a decrease of the intracellular GlcN-6-P
concentration, the glmS mono-cistronic transcript is
stabilized in a process that depends on the sRNA GlmZ
encoded in the hemY–aslA intergenic region (4). This
sRNA is synthesized as a 210nt long precursor and
subsequently processed, presumably by RNase III, to
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intracellular GlcN-6-P concentration, the full-length form
of GlmZ accumulates and concomitantly stabilizes the
glmS transcript, giving rise to higher GlmS synthesis levels
(4). Software analysis predicts that base-pairing of GlmZ
with the glmS message would disrupt an inhibitory stem
loop structure within the glmS leader RNA that buries the
ribosomal binding site. Therefore, the observed stabiliza-
tion of the glmS mRNA could be the consequence of
activation of glmS translation (4). Interestingly, most of
the supposedly base-pairing nucleotides are removed from
GlmZ upon processing, which explains that exclusively
full-length GlmZ can activate glmS.
A second sRNA, GlmY, was identiﬁed to cause GlmS
overproduction, when overexpressed from a plasmid (9).
GlmY is encoded in the purL–yfhK intergenic region
and evidence suggests that it is transcribed from a s
54-
dependent promoter (9). GlmY has been reported to exist
in two diﬀerent sizes of 184 and 148nt, respectively. The
shorter and more abundant form was suggested to result
from 30 end processing of the longer variant (9,10).
However, the mechanism by which GlmY may activate
the glmS mRNA and whether there is an interference with
GlmZ is currently not known.
In addition, mutations in two genes, yhbJ and pcnB,
have been identiﬁed to cause overexpression of GlmS
by activation of the GlmZ-mediated pathway: in both
mutants full-length GlmZ accumulates and stabilizes the
glmS mRNA resulting in dramatic overexpression of
GlmS (4,6). Gene yhbJ is present in the rpoN operon
coding for s
54 and homologues of the phosphotransferase
system (PTS). YhbJ contains an ATP-binding motif and
a putative RNA-binding domain, but the mechanism
by which it stimulates processing of GlmZ remains elusive.
Gene pcnB codes for poly(A) polymerase I (PAP I)
responsible for adding short poly (A) tails to the 30 ends
of transcripts, which may facilitate their subsequent
degradation (11–13). The activity of PAP I is in particular
required for the degradation of RNA molecules that
contain tightly folded secondary structures at their 30
end and lack a terminal single-stranded region (14,15).
These may be decay intermediates or primary transcripts
carrying a rho-independent terminator at the 30-end (16).
Polyadenylation is believed to make these substrates
accessible to further degrading RNases like RNase II
and polynucleotide phosphorylase (PNPase), the latter
being part of the degradosome. In addition, PAP I plays a
role in plasmid copy number control by governing the
turnover of regulatory RNAs and is involved in the
disposal of defective RNA molecules (17,18).
In the present study, we analyzed how GlmZ, GlmY
and PAP I act together in the regulation of glmS
expression. We show that upon an increase of the cellular
amount of sRNA GlmY, the full-length form of the sRNA
GlmZ accumulates and in turn activates glmS expression.
GlmY has no eﬀect on glmS expression in the absence of
GlmZ, while GlmY is not necessarily required for GlmZ-
dependent activation of glmS expression. Hence, GlmY
controls GlmZ, which then targets the glmS mRNA.
In addition, we demonstrate that GlcN-6-P controls
glmS expression by modulating the amount of GlmY.
GlmY subsequently transmits the signal to GlmZ, which
ﬁnally regulates the glmS mRNA. Our further data
show that the half-life of GlmY is tightly controlled by
polyadenylation. PAP I polyadenylates and destabilizes
GlmY and thereby indirectly contributes to the regulation
of cellular GlmZ and glmS amounts.
MATERIALS AND METHODS
Growthconditions, strains and plasmids
Cells were grown in LB at 378C under agitation (200
r.p.m.). When necessary, media were supplemented
with antibiotics (ampicillin: 50mg/ml, chloramphenicol:
15mg/ml, kanamycin: 30mg/ml). Nva-FMDP was added at
a concentration of 100mg/ml when the cultures reached an
OD600 of 0.3. The strains and plasmids used and their
relevant genotypes and characteristics are listed in Table 1.
See Table 2 for the list of oligonucleotides used in this
study. For DNA cloning, strain DH5a was used following
standard procedures (19). For construction of plasmid
pBGG149, glmY was ampliﬁed by PCR using primers
BG361 and BG373. The obtained DNA fragment was
digested with EcoRI and BamHI and subsequently
inserted between the same sites on plasmid pBGG179.
Plasmid pBGG179 carries the multiple cloning site of
plasmid pBAD33 (20) downstream of the strong PL
promoter. It was constructed by replacing the EcoRI–
BamHI fragment encompassing bglG in plasmid
pFDX1088 (K. Schnetz, unpublished) with a fragment
obtained by hybridizing the 50 phosphorylated oligonu-
cleotides BG418 and BG419, which are complementary
to each other. Newly constructed gene deletions were
made following standard procedures (21). They were
either marker-less clean deletions obtained with the help
of plasmid pCP20 as described or the deleted gene was
replaced by a chloramphenicol resistance cassette. T4GT7
transduction was used to move established deletions
tagged with antibiotic resistance markers between strains
(22). All strains constructed in this work were checked by
PCR using appropriate primers.
b-Galactosidase assays
LB cultures were inoculated from overnight cultures
in the same medium to an OD600 of 0.1. The cultures
were grown to an OD600 of 0.5–0.7 and harvested.
Determination of b-galactosidase activities was performed
as described (23). Enzyme activities are presented in
Miller units and are mean values of measurements
performed with samples from at least three independent
cultures.
RNA extraction and northernanalysis
RNA extraction was performed from samples harvested
from the exponential growth phase or from a set of
samples harvested along the growth curve of a single
culture using the RNeasy mini kit (Qiagen, Germany)
according to the manufacturer’s instructions.
Digoxigenin-labeled RNA probes against glmS, GlmZ
and GlmY RNAs were obtained by in vitro transcription
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Germany) and speciﬁc PCR generated fragments as
templates. The primers used for PCR were BG149 and
BG150 for glmS, BG230 and BG231 for glmZ and BG260
and BG261 for glmY. T7 RNA polymerase recognition
sequences were introduced into the PCR fragment by
the reverse primer. For northern blot analysis of
glmS mRNA, 5mg of total RNA was separated by
Table 1. Strains and plasmids used in this study
Strain/plasmid Genotype or relevant structures Reference, source or construction
A. strains
IBPC903 as N3433, but  pcnB::kan (6)
N3433 HfrH, lacZ43, , relA1, spoT1, thi1 (37)
R1279 CSH50 (pho-bgl)201 (lac-pro) ara thi (38)
R2413 as R1279, but [ptsN, yhbJ, ptsO] (4)
Z8 as R1279, but attB::[aadA glmS-5’::lacZ] strp
R F0(pro
+) (4)
Z24 as R1279, but yhbJ::cat (4)
Z28 as R1279, but yhbJ, attB::[aadA glmS-5’::lacZ] strp
R F0(pro
+) (4)
Z37 as R1279, but yhbJ (4)
Z38 as R1279, but glmZ::cat, attB::[aadA glmS-5’::lacZ] strp
R F0(pro
+) PCR BG184/BG185! Z8; this work
Z44 as R1279, but glmZ::cat (4)
Z45 as R1279, but glmZ (4)
Z46 as R1279, but [ptsN, yhbJ, ptsO], glmZ::cat (4)
Z47 as R1279, but [ptsN, yhbJ, ptsO], glmZ Z46 cured from cat; this work
Z95 as R1279, but glmY::cat PCR BG248/BG 249! R1279; this work
Z96 as R1279, but glmY Z95 cured from cat; this work
Z105 as R1279, but glmZ, glmY::cat T4GT7 (Z95) ! Z45; this work
Z107 as R1279, but [ptsN, yhbJ, ptsO], glmZ, glmY::cat T4GT7 (Z95) ! Z47; this work
Z115 as R1279, but yhbJ, glmY::cat T4GT7 (Z95) ! Z37; this work
Z116 as R1279, but yhbJ, glmZ::cat T4GT7 (Z44) ! Z37; this work
Z129 as R1279, but pcnB::kan T4GT7 (IBPC903) ! R1279; this work
Z152 as R1279, but pcnB::kan, glmY::cat T4GT7 (Z95) ! Z129; this work
B. Plasmids
pBAD30 ori p15A, Para, MCS, bla (20)
pBGG84 glmZ under PAra-control in pBAD30 (4)
pBGG149 as pBGG179, but glmY downstream of  PL This work
pBGG179 ori pMB1, PL, MCS, bla This work
ori, origin of replication; MCS, multiple cloning site.
Table 2. Oligonucleotides used in this study
Primer Sequence
a Res. sites Position
b
BG149 CTGGCGCGGAAGTAAAACG glmS+676 to +694
BG150 CTAATACGACTCACTATAGGGAGAAGAACCCGGAACGTTA glmS+1144 to +1125
BG184 GGGATGTTATTTCCCGATTCTCTGTGGCATAATAAACGAGTGT
AGGCTGGAGCTGCTTCG
glmZ  39 to  1
BG185 CACCCGGAGGCAAGCACCTCCGGGGCCTTCCTGATACATCAT
ATGAATATCCTCCTTAGTTCCTATTCC
glmZ+248 to +207
BG230 GTAGATGCTCATTCCATCTC glmZ+1 to +20
BG231 CTAATACGACTCACTATAGGGagAAAACAGGTCTGTATGACAAC glmZ+172 to +152
BG248 CAACAAAGCCGGGAATTACCCGGCTTTGTTATGGAAGTGTAGG
CTGGAGCTGCTTCG
glmY+185 to +150
BG249 CTATTTTCTTTATTGGCACAGTTACTGCATAATAGTAACCCATAT
GAATATCCTCCTTAGTTCCTATTCC
glmY  40 to  1
BG260 AGTGGCTCATTCACCGAC glmY+1 to +18
BG261 CTAATACGACTCACTATAGGGAGATAAGGCGGTGCCTAACTC glmY+150 to +131
BG361 GCGAATTCAGTGGCTCATTCACCGAC EcoRI glmY+1 to +18
BG373 GGCGGATCCAGCGTTTCAAGGTGTTACTC BamHI glmY+254 to +233
BG418 P-AATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCA
GGCATGCAAGCTTG
MCS
c of pBAD33
BG419 P-GATCCAAGCTTGCATGCCTGCAGGTCGACTCTAGA
GGATCCCCGGGTACCGAGCTCG
MCS
c of pBAD33
DEOXYLI GATCCCGGGATCCACCACCA BamHI
RIBOLI P-UGGUGGUGGAUCCCGGGAUC
Pforw GATCCTGCAGAGTGGCTCATTCACCGAC PstI glmY+1 to +18
aRestriction sites are underlined. 50-phosphorylated oligonucleotides are marked with a P.
bPositions are relative to the ﬁrst nucleotide of the respective gene.
cMCS, multiple cloning site.
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then transferred to a positively charged nylon membrane
(Roche Diagnostics, Germany) using the VacuGene XL
vacuum blotting system (Amersham Biosciences, USA)
following the manufacturer’s protocol. For northern blot
analysis of GlmY and GlmZ, 5mg of total RNA was
separated on 7M urea/TBE/8% polyacrylamide gels
and subsequently transferred to the nylon membrane
by electroblotting in 0.5 TBE at 15V for 1h. Probe
hybridization and detection were carried out according to
the supplier’s instruction (DIG RNA Labelling kit, Roche
Diagnostics, Germany).
Determination of GlmY and GlmZ half-lifes
To measure sRNA half-lifes, transcription initiation was
inhibited by adding rifampicin to exponentially growing
cells to a ﬁnal concentration of 500mg/ml (time 0). Here,
10ml aliquots of the culture were harvested at suited time
intervals and rapidly mixed with an equal volume of
ethanol pre-equilibrated at  708C. Total RNAs were
extracted as described previously (24). Five micrograms
were loaded on a high resolution 6% denaturing
polyacrylamide gel, electrotransferred and hybridized
with
32P-labeled RNA probes as described previously
(24). To normalize the data, the same membrane was
subsequently hybridized with a
32P-labeled 5S rRNA
speciﬁc probe (50-ACTACCATCGGCGCTACGGC).
The signals were detected and quantiﬁed using a
PhosphoImager.
3’ RACE analysis of GlmY 3’ends
Total RNA was prepared as described (24) and 2.5mg
were ligated with 100pmol oligonucleotide RIBOLI using
20 units T4 RNA ligase (Promega) in a reaction buﬀer
containing 12.5mM ATP, 50mM HEPES pH 7.5, 20mM
MgCl2, 3.3mM DTT, 0.01mg/ml BSA and 10% DMSO
(25). After precipitation with ethanol, the pellet was
re-suspended in 20ml water. Five microlitres of this solu-
tion was annealed to 100pmol oligonucleotide DEOXYLI
in 10ml 50mM Tris-HCl (pH 8.5), 8mM MgCl2,3 0 m M
KCl, 100mM DTT. Synthesis of cDNA was performed
by incubating the annealing mix with 10 units of AMV
reverse transcriptase and 100mM dNTPs at 428C for 1h.
After addition of 100pmol primer Pforw, the entire cDNA
reaction was subjected to PCR ampliﬁcation. After
digestion of the PCR fragments at the PstI and BamHI
sites introduced by the primers, the DNA fragments were
cloned into the vector pT3T718U (Pharmacia) digested
with the same enzymes. After isolation of recombinant
clones, the inserts were ampliﬁed using vector-speciﬁc
primers and the PCR fragments were sequenced.
RESULTS
YhbJaffects theamount ofthe small RNA GlmY
The localization of yhbJ in the rpoN operon and its high
degree of conservation in the genomes of proteobacteria
(26) raised the possibility that YhbJ might have a global
function and that it could also be a regulator of sRNAs
other than GlmZ. Therefore, we tested in northern
experiments whether a yhbJ mutation would also aﬀect
other candidate sRNAs known to be expressed in E. coli
(7,8). These experiments revealed that the sRNA GlmY is
less prevalent in the yhbJ mutant in comparison to the
wild-type strain whereas other tested sRNAs were
unaﬀected (our unpublished results). To investigate the
fate of GlmY in more detail, we isolated total RNAs of
the wild-type strain and the yhbJ mutant at diﬀerent time
points during growth and analyzed them in northern
experiments using probes speciﬁc for glmS, GlmZ and
GlmY, respectively. In the wild-type strain, both forms of
the sRNA GlmZ were detectable and almost no glmS
transcript accumulated (Figure 1, ﬁrst and second panels,
respectively). In contrast, in the yhbJ mutant processing
Figure 1. YhbJ has opposite eﬀects on the amounts of GlmZ and
GlmY. Northern blot analysis of RNA samples collected at various
time points during growth of strains R1279 (wild-type) and Z37
(yhbJ). The corresponding growth curves are shown at the top. The
RNAs were hybridized with probes speciﬁc for glmS (ﬁrst panel), for
GlmZ (second panel) and for GlmY (third panel). The ethidium-
bromide-stained gel is shown as loading control at the bottom. The
shorter variants of GlmZ and GlmY are designated with an asterisk
(throughout this study). The sizes of the molecular weight marker
(in kb) are given at the left (ﬁrst panel).
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length GlmZ and concomitantly in the accumulation of
glmS mRNA, which is in perfect agreement with previous
results (4). Interestingly, GlmY behaved very diﬀerent
from GlmZ: in the wild-type strain the short variant of
GlmY (subsequently designated GlmY
  in this report) was
detectable at all time-points and accumulated when the
cells entered the stationary growth phase as observed
previously (10), whereas in the yhbJ mutant GlmY
  was
exclusively detectable in the early exponential growth
phase (Figure 1, third panel). Full-length GlmY was
present in much lower amounts in the wild-type, and only
detectable in stationary phase, whereas in the yhbJ mutant
it was not detectable at all. In conclusion, it appears that a
yhbJ mutation has opposite eﬀects on the two sRNAs:
whereas GlmZ is stabilized in its full-length form, GlmY
becomes destabilized.
GlmY isdispensable forthe GlmZ-mediated activation
ofglmS expression
Our data suggest that YhbJ controls the cellular amounts
of the sRNAs GlmZ and GlmY. Therefore, we asked
whether GlmY would also have a role in the GlmZ-
mediated control of glmS expression. To address this
question, we deleted the glmY gene and combined this
mutation with glmZ and/or yhbJ mutations. The
resulting strains were grown to exponential phase and
total RNAs were prepared and subsequently probed in
northern experiments for the glmS, GlmZ and GlmY
RNAs, respectively (Figure 2A). As already shown before,
the glmS transcript as well as full-length GlmZ strongly
accumulate in yhbJ mutants, whereas the amount of
GlmY
  decreases in comparison to the wild-type
(Figure 2A, lanes 1–3). As expected from previous data
(4), the accumulation of the glmS transcript was abolished
in the glmZ yhbJ double mutant (Figure 2A,
top panel, lane 7), demonstrating once again that up-
regulation of glmS in the yhbJ mutant relies on GlmZ. In
contrast, the yhbJ glmY double mutant still over-
produced the glmS transcript whereas it was undetectable
in the yhbJ glmZ glmY triple mutant (Figure 2A, top
panel, lanes 8 and 9). In addition, in the yhbJ glmY
double mutant, full-length GlmZ accumulated like in the
yhbJ single mutant (Figure 2A, medium panel, lanes 2
and 8). Furthermore, no prominent diﬀerences in glmS
and GlmZ RNA amounts were detectable between the
wild-type and the glmY mutant (Figure 2A, compare
lanes 5 and 1). Taken together, a glmY mutation appears
to have no eﬀect on glmS- and GlmZ-levels, neither in the
wild-type nor in the yhbJ mutant. These results suggested
that GlmY is dispensable for the GlmZ-dependent
activation of glmS expression, at least in this mutant
background. To see, whether this is also the case in yhbJ
+
strains, we tested the eﬀects of GlmZ overexpression in the
wild-type strain and the glmY mutant. We have shown
before that GlmZ overexpression activates glmS expres-
sion to some extent even in the wild-type suggesting that
GlmZ overproduction is able to partially overcome the
negative eﬀect exerted by YhbJ (4). To see whether this is
also the case in a glmY mutant, we introduced a plasmid
carrying glmZ downstream of the arabinose-inducible
PBAD promoter into the wild-type strain and the glmY
mutant. Transformants carrying the empty expression
vector pBAD30 served as controls. The cells were grown
in the presence of arabinose and total RNAs were
extracted and subsequently analyzed in a northern
Figure 2. Activation of glmS expression by GlmZ is independent of
GlmY. (A) Northern blot analyses to determine the eﬀects of yhbJ,
glmZ and glmY mutations, alone or in various combinations, on
the glmS, GlmY and GlmZ transcript levels. Total RNAs of strains
R1279 (lane 1), Z37 (lane 2), R2413 (lane 3), Z44 (lane 4), Z95 (lane 5),
Z105 (lane 6), Z116 (lane 7), Z115 (lane 8) and Z107 (lane 9) were
hybridized with a glmS speciﬁc probe (top panel), a GlmZ speciﬁc
probe (medium panel) and a GlmY speciﬁc probe (bottom panel). The
relevant genotypes are given at the top. (B) Northern blot experiment
to determine the eﬀect of GlmZ overexpression on glmS transcript
levels. Strains R1279 (wild-type) and Z96 (glmY) were transformed
with pBAD30 (empty vector; lanes 2 and 4) or pBGG84 (glmZ on
pBAD30, lanes 3 and 5) and total RNA was isolated from arabinose-
induced cultures and hybridized with a glmS probe. The untransformed
yhbJ mutant served as control (lane 1).
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expected, in the wild-type strain the presence of the
GlmZ overproduction construct caused accumulation of
the glmS mRNA whereas the empty expression vector had
no eﬀect (Figure 2B, lanes 2 and 3). The virtually same
result was obtained when the glmY mutant was tested
(Figure 2B, lanes 4 and 5). This result clearly demonstrates
that GlmZ per se does not require the presence of GlmY
for the activation of glmS expression, which suggests that
base-pairing between GlmZ and glmS mRNA does not
depend on GlmY.
Overexpression of GlmY induces glmS expression in
aGlmZ-dependent manner
Next, we investigated the eﬀect of GlmY overexpression.
For this purpose, the glmY gene was cloned on a plasmid
under control of the strong constitutively active PL
promoter. The resulting plasmid was introduced into the
wild-type strain that carried a glmS0–lacZ reporter fusion
expressed from a constitutive promoter on the chromo-
some (4). This fusion is perfectly regulated by GlmZ and
YhbJ. The presence of the glmY expression plasmid led to
induction of glmS0–lacZ expression (Figure 3A), whereas
no increase in b-galactosidase activity was detectable when
the empty expression vector was present (data not shown).
To conﬁrm these results we performed northern experi-
ments using probes speciﬁc for glmS and GlmZ. In the
wild-type strain, overexpression of glmY caused the
strong accumulation of the glmS transcript and concomi-
tantly of full-length GlmZ sRNA (Figure 3B, lanes 1
and 2). Hence, it can be concluded that GlmY positively
regulates the glmS mRNA, which is in agreement with
a recent publication demonstrating that GlmY over-
expression causes overproduction of GlmS protein (9).
Our additional observation that GlmY overproduction
stabilizes full-length GlmZ, raises the possibility that
GlmY acts on glmS indirectly via GlmZ. To test this idea,
we repeated the experiments described above in glmZ
and glmZ yhbJ mutants. In these strains, GlmY
overproduction had no stimulatory eﬀect, neither on
expression of the glmS0–lacZ reporter fusion (Figure 3A)
nor on the glmS transcript level as detected by northern
analysis (Figure 3B, lanes 5–8). Next, we tested the eﬀect
of GlmY overexpression in the yhbJ mutant. In this strain
glmS strongly accumulates and the glmS0–lacZ reporter
fusion is highly expressed (Figure 3A and B, lane 3).
Additional overexpression of the glmY construct, how-
ever, had no additive eﬀect on the GlmZ and glmS RNA
levels (Figure 3B, lanes 3 and 4) and on the expression of
the glmS0–lacZ fusion (Figure 3A).
So far, our data show that a high cellular amount of
GlmY induces glmS expression in a process that depends
on GlmZ, whereas GlmZ can positively regulate the glmS
mRNA independently from GlmY. Hence, GlmY acts
upstream and may act in concert with YhbJ to regulate
GlmZ, which in turn targets the glmS mRNA.
GlmY receives and transmits the GlcN-6-P signal to glmS
viaGlmZ
We have recently shown that the sRNA GlmZ mediates
the feedback control of glmS expression by GlcN-6-P.
When the intracellular GlcN-6-P concentration decreases,
full-length GlmZ accumulates and activates glmS expres-
sion (4). Our results above demonstrate that GlmY acts
upstream of GlmZ in the activation of glmS mRNA. This
raised the possibility that GlmY receives the GlcN-6-P
signal and relays it to GlmZ, which then stimulates
glmS expression. To address this question, we used
Figure 3. GlmY requires GlmZ for the activation of glmS expression. (A) Overexpression of glmY induces expression of the glmS’-lacZ reporter
fusion in the wild-type but not in the glmZ mutant. Strains Z8 (wild-type), Z38 (glmZ) and Z28 (yhbJ) were grown in the absence (grey bars) or
presence of the glmY overproducing plasmid pBGG149 (black bars) and the b-galactosidase activities were determined. (B) Northern blot analysis of
glmS and GlmZ RNAs in strains overproducing GlmY. Total RNAs were isolated from strains R1279 (wild-type), Z37 (yhbJ), Z45 (glmZ) and
Z116 (yhbJ, glmZ), which were either untransformed (lanes 1, 3, 5 and 7) or transformed with plasmid pBGG149 overproducing GlmY (lanes 2,
4, 6 and 8). The RNAs were hybridized with a glmS probe (upper panel) and a GlmZ probe (second panel).
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2,3-diaminopropanoic acid. This compound selectively
inhibits GlmS enzymatic activity in vivo (27) and thereby
causes a decrease in the intracellular GlcN-6-P concentra-
tion, which leads to induction of glmS expression via
accumulation of full-length GlmZ (4). To see whether the
intracellular GlcN-6-P concentration also aﬀects the
amount of GlmY present in the cell, the wild-type strain
was grown to exponential phase and after splitting of the
culture, growth was continued in either the absence or
presence of Nva-FMDP. Subsequently, cells were har-
vested at three diﬀerent time-points (30min, 1h and 2h)
and total RNAs were isolated and subjected to northern
analyses using probes directed against glmS, GlmZ and
GlmY. As expected from previous data (4), Nva-FMDP
caused the accumulation of glmS transcript and simulta-
neously of full-length GlmZ (Figure 4, ﬁrst and second
panels, compare lanes 1–3 with lanes 4–6). Intriguingly,
presence of Nva-FMDP also caused the accumulation of
GlmY
  (Figure 4, third panel), demonstrating that the
GlmY
  amount in the cell is controlled by GlcN-6-P. To
test whether the accumulation of GlmZ and glmS RNAs
upon depletion of GlcN-6-P is the direct consequence of
accumulation of GlmY, we repeated the experiment using
a glmY mutant. Indeed, Nva-FMDP had no large eﬀect
in this mutant, i.e. accumulation of full-length GlmZ and
up-regulation of glmS mRNA was abolished (Figure 4,
ﬁrst and second panel, lanes 7–9). However, it appears
that the processed form of GlmZ was present in a
somewhat higher amount in the Nva-FMDP-treated
glmY mutant in comparison to the other conditions
(Figure 4, second panel). The reason for this phenomenon
remains to be determined. In sum, the data show that
GlcN-6-P controls glmS expression by regulating the
amount of GlmY, which subsequently transmits the signal
via GlmZ to glmS mRNA.
Mutation of poly(A) polymerase PAP-I increases the
stabilities ofboth GlmZ and GlmYsRNAs
Mutation of pcnB encoding poly (A) polymerase PAP-I
leads to strong accumulation of glmS mRNA and hence
to overproduction of GlmS (6). In addition, full-length
GlmZ accumulates in a pcnB mutant (4) suggesting that
PAP-I aﬀects a factor upstream in the signaling cascade
controlling glmS expression rather than the glmS mRNA
itself. To ﬁnd out which of the known factors governing
glmS mRNA accumulation is controlled by PAP-I, we
analyzed the fates of glmS, GlmZ and GlmY RNAs. For
this purpose, we isolated total RNAs of the pcnB mutant
and the wild-type at diﬀerent time points during growth
and analyzed them in northern experiments using probes
speciﬁc for the various RNAs. These experiments revealed
that in the pcnB mutant glmS mRNA and concomitantly
full-length GlmZ strongly accumulate in the exponential
growth phase (Figure 5, top and medium panels). The
shorter form of GlmZ was hardly detectable in the pcnB
mutant, suggesting that GlmZ processing is aﬀected. In
parallel, much higher amounts of GlmY
  were detectable
in the pcnB mutant in comparison to the wild-type strain
(Figure 5, third panel). When cells entered stationary
phase the amounts of glmS mRNA and GlmZ drastically
decreased both in the wild-type as well as in the pcnB
strain. This suggests superimposition of a negative control
mechanism down-regulating GlmZ and therefore glmS
during this growth phase, regardless of the activity of
PAP-I.
The higher amounts of GlmY
  and full-length GlmZ
detectable in the pcnB mutant during exponential
growth could either mean that these sRNAs are stabilized
in the pcnB mutant or alternatively that their expression
level is altered. To discriminate between these possibilities,
we determined the half-lifes of GlmZ and GlmY in the
pcnB mutant and the wild-type strain, respectively.
To this end, these strains were grown to exponential phase
and total RNAs were prepared from samples harvested at
diﬀerent time-points following the addition of rifampicin
and analyzed in northern experiments using high resolu-
tion acrylamide gels. These experiments showed that the
half-lifes of both GlmZ and GlmY were dramatically
increased in the pcnB background. Quantiﬁcation and
normalization of the signal intensities relative to the 5S
rRNA signal revealed a half-life of 1.7 0.1min of full-
length GlmZ in the wild-type strain (Figure 6A), which
corresponds well with the previously reported half-life of
 2min for GlmZ observed in wild-type cells during the
exponential phase (10). In contrast, in the pcnB mutant
the half-life of GlmZ increased to of 20.2 0.1min
(Figure 6A). The shorter GlmZ
  species was not detectable
Figure 4. GlmY is essential for transduction of the GlcN-6-P signal to
glmS and is itself regulated by GlcN-6-P. Northern blotting experi-
ments to determine the eﬀect of the inhibitor of GlmS enzymatic
activity, Nva-FMDP, on the glmS transcript (glmS probe; top), on
GlmZ (GlmZ probe; second panel) and on GlmY (GlmY probe; third
panel) in strains R1279 (wild-type) and Z95 (glmY::cat). Samples
were harvested at the time indicated after addition of Nva-FMDP.
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is inhibited in the absence of PAP I. In contrast, a new
shorter and low abundant GlmZ variant appeared in the
pcnB mutant and its amount slightly increased with
time. Similarly to GlmZ, GlmY
  was highly stabilized in
the pcnB mutant (Figure 6B). In this case, the half-life
increased from 1.4 0.1min in the wild-type to
6.7 0.1min in the pcnB mutant. Interestingly, in the
wild-type strain but not in the pcnB mutant, a smear of
slightly larger transcripts running above GlmY
  in the gel
was detectable. Such a size heterogeneity could be caused
by the presence of poly(A) tails of diﬀerent length in
GlmY, as also previously observed for another sRNA
subject to polyadenylation (28). No such smear could
be observed for GlmZ (Figure 6A). In sum, the data
demonstrate that both GlmZ and GlmY
  are stabilized by
a pcnB mutation.
Poly(A) polymerase PAP-I polyadenylates and destabilizes
thesRNA GlmY and thereby indirectly controls the GlmZ
andglmS mRNAlevels
Our data showed that the amount of GlmY positively
controls the amount of full-length GlmZ and thereby up-
regulates glmS. Hence, the stabilization of the GlmZ and
glmS RNAs in the pcnB mutant could be the indirect
consequence of GlmY
  stabilization alone. To test this
idea, we compared the GlmZ and glmS amounts present in
pcnB and pcnB glmY mutants. Total RNAs were
isolated from samples harvested at diﬀerent time points
during growth and analyzed in northern experiments.
These experiments showed that a glmY mutation prevents
the accumulation of the glmS and full-length GlmZ RNAs
in pcnB mutants (Figure 7A). In the pcnB glmY double
mutant the glmS and GlmZ RNA amounts and patterns
were very similar to those detectable in the wild-type strain
(Figure 5). This shows that GlmY is the target of PAP I
and that the eﬀects on GlmZ and glmS are indirect and the
consequence of modulation of GlmY amounts. To obtain
direct evidence that GlmY is polyadenylated by PAP I, we
applied a 30-RACE approach (29) that allows to selectively
amplify GlmY 30 ends by PCR and to determine their
sequences after cloning. Of the altogether 19 clones
analyzed, all corresponded to the shorter GlmY
  variant
encompassing 147, 148 or 149nt of the glmY sequence
(Figure 7B). Nine clones harbored at the 30 end short
extensions of two or three A residues, which are added
post-transcriptionally (Figure 7B). This result suggests
that about half of the shorter GlmY
  species are
polyadenylated by PAP-I in vivo.
DISCUSSION
In E. coli, the glmS gene encoding GlcN-6-P synthase, a
central metabolic enzyme required for the synthesis of
bacterial peptidoglycan, is subject to post-transcriptional
regulation by the two small RNAs GlmY and GlmZ.
Overexpression of either of these sRNAs stabilizes the
Figure 6. Mutation of pcnB strongly increases the half-lifes of full-length GlmZ and GlmY
 . Strains N3433 (wild-type) and IBPC903 (pcnB) were
treated with rifampicin for the inhibition of transcription initiation and subsequently samples were harvested at the indicated times and the total
RNAs were isolated. The RNAs were analysed by northern blotting using probes speciﬁc for GlmZ (A, top panel), GlmY (B, top panel) and 5S
rRNA (bottom panels in A and B).
Figure 5. Mutation of pcnB results in accumulation of glmS, full-length
GlmZ and GlmY
  RNAs. Northern blot analysis of RNA samples
collected at various times during growth of strains R1279 (wild-type)
and Z129 (pcnB). Speciﬁc RNAs were detected using probes
directed against glmS (upper panel), GlmZ (second panel) and GlmY
(third panel).
Nucleic Acids Research, 2008, Vol. 36, No. 8 2577glmS monocistronic transcript and results in overproduc-
tion of GlmS protein [(4,9); this work]. In this work, we
show that there is a hierarchical interdependence between
the two sRNAs in the control of glmS expression: GlmY
requires the presence of GlmZ to activate glmS expression.
In contrast, GlmZ can activate glmS expression autono-
mously and does not require GlmY. Third, a high cellular
amount of GlmY prevents processing of GlmZ leading
to accumulation of its full-length form. These ﬁndings
suggest that GlmY acts indirectly on glmS by modulating
the cellular amount of full-length GlmZ. Hence, unlike
GlmZ, GlmY may not base-pair with the glmS mRNA,
but act upstream of GlmZ in the signal cascade controlling
glmS expression (see model in Figure 8). Furthermore, we
show that GlmY is also part of the GlcN-6-P dependent
signaling cascade controlling glmS expression. In the wild-
type, a decrease of the intracellular GlcN-6-P concentra-
tion causes accumulation of GlmY and concomitantly of
full-length GlmZ and glmS mRNA. In a glmY mutant
GlcN-6-P has no such eﬀect: full-length GlmZ and glmS
mRNA do not anymore accumulate. This suggests that
GlcN-6-P controls glmS indirectly, via the GlmY-GlmZ
signal cascade: depletion of the GlcN-6-P level causes
accumulation of GlmY, which stabilizes full-length GlmZ
that ﬁnally activates glmS expression (Figure 8). GlmY is
conserved in the genomes of several Enterobacteriaceae
(9). As judged from blast analyses, all bacteria that possess
the glmY gene also contain glmZ (data not shown). This
suggests that these two sRNAs constitute an evolutionary
conserved regulatory module.
How does GlmY control processing of GlmZ? One
possibility is that GlmY negatively controls expression of
a factor required for GlmZ processing. Our data obtained
so far suggest that the function of GlmY may involve
YhbJ, a putative RNA-binding protein encoded in the
rpoN operon. In the yhbJ mutant, neither the absence nor
the overproduction of GlmY had any eﬀect on the already
high amounts of full-length GlmZ and glmS mRNA
(Figures 2 and 3). This suggests that GlmY acts upstream
or in concert with YhbJ in the same pathway to regulate
GlmZ (Figure 8). Hence, it is conceivable that GlmY
controls the cellular amount of YhbJ, which in turn
governs processing of GlmZ. However, so far our experi-
ments did not detect any diﬀerences in yhbJ expression
levels in glmY mutants or over-expressing strains (data
not shown). In an alternative scenario, YhbJ may directly
bind the sRNAs. Binding of GlmY could out-compete
Figure 7. PAP I polyadenylates GlmY
  and thereby indirectly
destabilizes the glmS and GlmZ RNAs. (A) Northern blot analysis of
total RNA samples collected at various times during growth of strains
Z129 (pcnB) and Z152 (pcnB, glmY). The glmS (top panel) and
GlmZ (second panel) RNAs were detected using speciﬁc probes,
respectively. (B)3 0RACE analysis of GlmY 30 ends in the wild-type.
Total RNA of wild-type strain R1279 was subjected to 30 RACE
analysis. The obtained sequences and the frequency of their occurrence
are shown. Adenosine residues unequivocally added by PAP I are
depicted in bold.
Figure 8. Model for the regulation of glmS expression by GlcN-6-P,
PAP I, GlmY and GlmZ. PAP I polyadenylates and thereby
destabilizes the sRNA GlmY. When the intracellular GlcN-6-P
concentration drops, the short form of GlmY accumulates, which
leads to stabilization of the full-length form of the sRNA GlmZ.
Similarly, diminished PAP I activity causes accumulation of GlmY.
Presumably, GlmY acts in concert with protein YhbJ to modulate
processing of GlmZ by a still unknown mechanism. The accumulation
of full-length GlmZ in turn stabilizes the glmS transcript that derives
from processing of the glmUS primary transcripts by RNase E. GlmZ
presumably base-pairs with the glmS mRNA, which may be assisted
by Hfq (4).
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accumulation in the active full-length form. Binding of
GlmY by a protein like YhbJ would presumably also alter
its accessibility to degrading RNases like PNPase (see
below) and could therefore explain the low GlmY amount
present in yhbJ mutants (Figures 1 and 2). Binding by a
speciﬁc protein would require some similarities on the
sequence and/or structural level of the two sRNAs.
Interestingly, GlmY shares 63% sequence identity with
GlmZ and software analysis predicts strikingly similar
overall secondary structures for both sRNAs (Figure S1 in
Supplementary Material). The structures consist of two
large imperfect stem loops and an additional terminator
stem loop at the 30 end. In addition, the second stem loop
carries a characteristic pear-shaped bulge. A sequence
alignment of GlmY and GlmZ sRNAs from 11 diﬀerent
species reveals a high degree of sequence identity in the 50
parts of the molecules preceding the processing sites
(Figure S1). This homology does not extend into the
putative base-pairing region within GlmZ. Taken together
GlmY and GlmZ appear to be homologous sRNAs.
The clariﬁcation of the relationship between GlmY and
GlmZ in the activation of glmS expression allowed us to
address the role of PAP I in this regulatory circuit.
In mutants defective for PAP I the GlmS protein strongly
and speciﬁcally accumulates as a result of the accumula-
tion of glmS mRNA (6). This drastic eﬀect suggested a
speciﬁc role for PAP I in glmS gene regulation. In this
work, we show that PAP I exerts its destabilizing eﬀect on
glmS indirectly, by controlling the stability of sRNA
GlmY: PAP I polyadenylates GlmY
  and destabilizes it
thereby. In PAP I mutants GlmY
  accumulates, which
induces accumulation of full-length GlmZ and glmS. The
inactivation of PAP I has no eﬀect in glmY mutants,
demonstrating that PAP I acts exclusively via GlmY on
glmS expression (Figure 8).
As a result of 30 processing GlmY is present in two
forms in wild-type strains, of which the shorter form
GlmY
  is much more abundant [(10); this work]. It is this
shorter variant that accumulates in pcnB mutants
(Figure 5) and that we detected as polyadenylated species
in the 30RACE experiments (Figure 7B). Therefore, it can
be concluded that the shorter GlmY
  variant is respon-
sible for stabilization of full-length GlmZ, which causes
activation of glmS expression. The 30 tail following the
GlmY processing site should have no role in this process.
Indeed, in close relatives of E. coli, the sequence of glmY
corresponding to the shorter GlmY
  variant is highly
conserved, whereas the sequence downstream of the
processing site is not. This is further supported by the
ﬁnding that heterologous GlmY from Erwinia carotovora
is able to activate expression of E. coli glmS, although the
sequence of its 30 tail is completely diﬀerent from that of
E. coli GlmY (9).
It is an accepted model that PAP I preferably poly-
adenylates RNA molecules that bear a 50-monophosphate
and a secondary structure at the 30 end and that may
result from a preceding endonucleolytic processing
event. Polyadenylation is thought to provide a toehold
for RNases like polynucleotide phosphorylase (PNPase)
and RNase R and may help them to get through the 30
secondary structures (17,18). According to software
analysis processed GlmY
  carries an extensive secondary
structure at the 30 end, followed by only four or ﬁve
unpaired nucleotides (9) (Figure 7B and Figure S1 in
Supplementary Material). This stretch is presumably too
short to make GlmY
  accessible for subsequently degrad-
ing RNases and polyadenylation may overcome this
barrier. In many cases PNPase is responsible for the
degradation of polyadenylated RNAs and our further
data show that GlmY also accumulates in PNPase
mutants (data not shown). Hence, it is conclusive that
polyadenylation makes GlmY more accessible for PNPase
which subsequently degrades it to shorter oligoribonu-
cleotides. It has been suggested that the Hfq protein
may facilitate polyadenylation of RNAs by PAP I (30).
However, mutation of hfq has no eﬀect on GlmY amounts
present in the cell (data not shown), making it unlikely
that Hfq contributes to GlmY decay.
The way by which PAP I regulates activity of GlmY,
a regulatory RNA, is not unprecedented. RNA I, the
regulatory RNA that represses replication of ColEI-type
plasmids is stabilized 10-fold in pcnB mutants. The
form of RNA I that accumulates in pcnB mutants and
which is active in repression has undergone a processing
event that normally initiates RNA I decay by the PAP I/
PNPase pathway (13,31). Similar observations have
been reported for CopA RNA-regulating plasmid R1
replication and the Sok antisense RNA from plasmid R1
that inhibits translation of the hok mRNA (32–34).
Recently, the turnover of SraL, a small RNA of unknown
function, has been reported to be regulated by PAP I (28).
Half-life is a critical parameter for the function of
regulatory RNAs since their activities unlike that of
protein regulators usually cannot be reversibly switched
on/oﬀ with the help of co-factors (35). Therefore, to
function appropriately, it is necessary that trans-encoded
regulatory RNAs are consumed upon action (36) or
rapidly degraded. Taken together, it appears that another
major domain of PAP I is the control of turnover of
certain regulatory RNAs, which may provide the pre-
requisite for switching their amounts and thereby their
activities in the cell.
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